Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL249):

Molecule: APREPITANT
ChEMBL ID: CHEMBL1471
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: FOSAPREPITANT DIMEGLUMINE
ChEMBL ID: CHEMBL1201782
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: NETUPITANT
ChEMBL ID: CHEMBL206253
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2014

Molecule: ROLAPITANT HYDROCHLORIDE
ChEMBL ID: CHEMBL3707330
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015

Molecule: FIGOPITANT
ChEMBL ID: CHEMBL2104927
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DNK333
ChEMBL ID: CHEMBL105060
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VESTIPITANT MESYLATE
ChEMBL ID: CHEMBL2104992
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ORVEPITANT
ChEMBL ID: CHEMBL2105667
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SERLOPITANT
ChEMBL ID: CHEMBL447955
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TRADIPITANT
ChEMBL ID: CHEMBL3544984
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BURAPITANT
ChEMBL ID: CHEMBL3544947
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VOFOPITANT
ChEMBL ID: CHEMBL522302
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: EZLOPITANT
ChEMBL ID: CHEMBL515966
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CASOPITANT
ChEMBL ID: CHEMBL1672054
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: FOSNETUPITANT CHLORIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL3989919
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: ELINZANETANT
ChEMBL ID: CHEMBL4802157
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2327):

Molecule: IBODUTANT
ChEMBL ID: CHEMBL266125
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: SAREDUTANT
ChEMBL ID: CHEMBL308148
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NEPADUTANT
ChEMBL ID: CHEMBL1908318
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4429):

Molecule: TALNETANT
ChEMBL ID: CHEMBL10188
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PAVINETANT
ChEMBL ID: CHEMBL3545233
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FEZOLINETANT
ChEMBL ID: CHEMBL3608680
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: ELINZANETANT
ChEMBL ID: CHEMBL4802157
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2096670):

Molecule: PERAMPANEL
ChEMBL ID: CHEMBL1214124
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2012

Molecule: TOPIRAMATE
ChEMBL ID: CHEMBL220492
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: IRAMPANEL
ChEMBL ID: CHEMBL29741
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CX1739
ChEMBL ID: CHEMBL3707399
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PESAMPATOR
ChEMBL ID: CHEMBL5095022
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SELURAMPANEL
ChEMBL ID: CHEMBL3545042
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TEZAMPANEL
ChEMBL ID: CHEMBL3989703
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DASOLAMPANEL
ChEMBL ID: CHEMBL2103869
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BECAMPANEL
ChEMBL ID: CHEMBL3989682
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FARAMPATOR
ChEMBL ID: CHEMBL1276138
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MIBAMPATOR
ChEMBL ID: CHEMBL1277001
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MK-8777
ChEMBL ID: CHEMBL3707401
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ZONAMPANEL
ChEMBL ID: CHEMBL119625
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: OSAVAMPATOR
ChEMBL ID: CHEMBL4594403
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2009):

Molecule: TALAMPANEL
ChEMBL ID: CHEMBL61872
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4016):

Molecule: TALAMPANEL
ChEMBL ID: CHEMBL61872
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4531):

Molecule: OLITIGALTIN
ChEMBL ID: CHEMBL4297442
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BELAPECTIN
ChEMBL ID: CHEMBL4297577
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown

Molecule: DAVANAT
ChEMBL ID: CHEMBL4297960
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2094125):

Molecule: THEOPHYLLINE SODIUM GLYCINATE
ChEMBL ID: CHEMBL1200578
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: ANAGRELIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200759
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: AMINOPHYLLINE
ChEMBL ID: CHEMBL1370561
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1940

Molecule: THEOPHYLLINE
ChEMBL ID: CHEMBL190
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1940

Molecule: OXTRIPHYLLINE
ChEMBL ID: CHEMBL1200434
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: LEVOSIMENDAN
ChEMBL ID: CHEMBL2051955
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: K-134
ChEMBL ID: CHEMBL284838
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ENOXIMONE
ChEMBL ID: CHEMBL249856
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ENSIFENTRINE
ChEMBL ID: CHEMBL4594287
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL3989384):

Molecule: PF-03732010
ChEMBL ID: CHEMBL2109534
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4622829):

Molecule: DANVATIRSEN
ChEMBL ID: CHEMBL4297739
Mechanism of Action: ANTISENSE INHIBITOR
Max Phase: 2.0
Molecule Type: Oligonucleotide

Molecule: DANVATIRSEN SODIUM
ChEMBL ID: CHEMBL4297244
Mechanism of Action: ANTISENSE INHIBITOR
Max Phase: -1.0
Molecule Type: Oligonucleotide
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4630889):

Molecule: CODRITUZUMAB
ChEMBL ID: CHEMBL4298089
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL402):

Molecule: LOVASTATIN
ChEMBL ID: CHEMBL503
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: CERIVASTATIN SODIUM
ChEMBL ID: CHEMBL1200563
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: PITAVASTATIN CALCIUM
ChEMBL ID: CHEMBL1237061
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: FLUVASTATIN SODIUM
ChEMBL ID: CHEMBL2218894
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1993

Molecule: ROSUVASTATIN CALCIUM
ChEMBL ID: CHEMBL1744447
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: PRAVASTATIN SODIUM
ChEMBL ID: CHEMBL690
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: ATORVASTATIN CALCIUM
ChEMBL ID: CHEMBL393220
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: SIMVASTATIN
ChEMBL ID: CHEMBL1064
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: PITAVASTATIN MAGNESIUM
ChEMBL ID: CHEMBL3989923
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: PITAVASTATIN SODIUM
ChEMBL ID: CHEMBL3989920
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL1969):

Molecule: METYROSINE
ChEMBL ID: CHEMBL1200862
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2062):

Molecule: DANTROLENE SODIUM
ChEMBL ID: CHEMBL928
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL246):

Molecule: MIRABEGRON
ChEMBL ID: CHEMBL2095212
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2012

Molecule: LY377604
ChEMBL ID: CHEMBL2012520
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SOLABEGRON
ChEMBL ID: CHEMBL208427
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VIBEGRON
ChEMBL ID: CHEMBL2107826
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: RAFABEGRON
ChEMBL ID: CHEMBL279260
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AMIBEGRON HYDROCHLORIDE
ChEMBL ID: CHEMBL545437
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: RITOBEGRON
ChEMBL ID: CHEMBL2107773
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4644):

Molecule: MODIMELANOTIDE
ChEMBL ID: CHEMBL3545104
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL280):

Molecule: DOXYCYCLINE
ChEMBL ID: CHEMBL1200699
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: DOXYCYCLINE CALCIUM
ChEMBL ID: CHEMBL2364574
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974

Molecule: DOXYCYCLINE HYCLATE
ChEMBL ID: CHEMBL3989740
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: APRATASTAT
ChEMBL ID: CHEMBL206815
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: REBIMASTAT
ChEMBL ID: CHEMBL76222
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CTS-1027
ChEMBL ID: CHEMBL440498
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL283):

Molecule: MARIMASTAT
ChEMBL ID: CHEMBL279785
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CTS-1027
ChEMBL ID: CHEMBL440498
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL1829):

Molecule: VORINOSTAT
ChEMBL ID: CHEMBL98
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: MOCETINOSTAT
ChEMBL ID: CHEMBL272980
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2028):

Molecule: PASIREOTIDE DIASPARTATE
ChEMBL ID: CHEMBL5314380
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2012

Molecule: PASIREOTIDE PAMOATE
ChEMBL ID: CHEMBL5314382
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2014

Molecule: VAPREOTIDE
ChEMBL ID: CHEMBL2103975
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Protein
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL3670):

Molecule: TRILOSTANE
ChEMBL ID: CHEMBL1200907
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2998):

Molecule: GEFAPIXANT
ChEMBL ID: CHEMBL3716057
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CAMLIPIXANT
ChEMBL ID: CHEMBL5095035
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL3273):

Molecule: SQUALAMINE LACTATE
ChEMBL ID: CHEMBL3989689
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TENAPANOR HYDROCHLORIDE
ChEMBL ID: CHEMBL3301627
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL5522):

Molecule: GRC-15300
ChEMBL ID: CHEMBL3707319
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL5705):

Molecule: VADADUSTAT
ChEMBL ID: CHEMBL3646221
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: MOLIDUSTAT
ChEMBL ID: CHEMBL3646118
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL3407319):

Molecule: TAREXTUMAB
ChEMBL ID: CHEMBL3301588
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL3712903):

Molecule: FRESOLIMUMAB
ChEMBL ID: CHEMBL1743022
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4630879):

Molecule: SABATOLIMAB
ChEMBL ID: CHEMBL4594575
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: COBOLIMAB
ChEMBL ID: CHEMBL4298123
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: LOMVASTOMIG
ChEMBL ID: CHEMBL4594602
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4630881):

Molecule: IERAMILIMAB
ChEMBL ID: CHEMBL4298009
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: RELATLIMAB
ChEMBL ID: CHEMBL3990044
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2022

Molecule: FIANLIMAB
ChEMBL ID: CHEMBL4298085
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: FAVEZELIMAB
ChEMBL ID: CHEMBL4297784
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: TEBOTELIMAB
ChEMBL ID: CHEMBL4594578
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: EFTILAGIMOD ALFA
ChEMBL ID: CHEMBL4594557
Mechanism of Action: VACCINE ANTIGEN
Max Phase: 2.0
Molecule Type: Unknown
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4630888):

Molecule: ROVALPITUZUMAB TESIRINE
ChEMBL ID: CHEMBL3990011
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody drug conjugate
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4804261):

Molecule: BIFONAZOLE
ChEMBL ID: CHEMBL277535
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL208):

Molecule: NORETHYNODREL
ChEMBL ID: CHEMBL1387
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1961

Molecule: ETONOGESTREL
ChEMBL ID: CHEMBL1531
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: MEGESTROL ACETATE
ChEMBL ID: CHEMBL1201139
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1971

Molecule: NORETHINDRONE ACETATE
ChEMBL ID: CHEMBL1201146
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1973

Molecule: MEDROXYPROGESTERONE ACETATE
ChEMBL ID: CHEMBL717
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1959

Molecule: NORETHINDRONE
ChEMBL ID: CHEMBL1162
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1962

Molecule: HYDROXYPROGESTERONE CAPROATE
ChEMBL ID: CHEMBL1200848
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1975

Molecule: DYDROGESTERONE
ChEMBL ID: CHEMBL1200853
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: PROGESTERONE
ChEMBL ID: CHEMBL103
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1976

Molecule: NORGESTREL
ChEMBL ID: CHEMBL2107797
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1968

Molecule: NORGESTIMATE
ChEMBL ID: CHEMBL1200934
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: LEVONORGESTREL
ChEMBL ID: CHEMBL1389
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: DESOGESTREL
ChEMBL ID: CHEMBL1533
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: ULIPRISTAL ACETATE
ChEMBL ID: CHEMBL260538
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: NORELGESTROMIN
ChEMBL ID: CHEMBL1200807
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: ETHYNODIOL DIACETATE
ChEMBL ID: CHEMBL1200624
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1966

Molecule: MIFEPRISTONE
ChEMBL ID: CHEMBL1276308
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: DROSPIRENONE
ChEMBL ID: CHEMBL1509
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: DANAZOL
ChEMBL ID: CHEMBL1479
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1976

Molecule: PF-05019702
ChEMBL ID: CHEMBL3545239
Mechanism of Action: ANTAGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LONAPRISAN
ChEMBL ID: CHEMBL146032
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TELAPRISTONE ACETATE
ChEMBL ID: CHEMBL2105694
Mechanism of Action: MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ONAPRISTONE
ChEMBL ID: CHEMBL1908373
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ASOPRISNIL
ChEMBL ID: CHEMBL267431
Mechanism of Action: MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ULIPRISTAL
ChEMBL ID: CHEMBL2103846
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: CHLORMADINONE ACETATE
ChEMBL ID: CHEMBL110691
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ALLYLESTRENOL
ChEMBL ID: CHEMBL2105618
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: CYPROTERONE ACETATE
ChEMBL ID: CHEMBL139835
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: SEGESTERONE ACETATE
ChEMBL ID: CHEMBL3707377
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: VILAPRISAN
ChEMBL ID: CHEMBL3989936
Mechanism of Action: MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: GESTODENE
ChEMBL ID: CHEMBL1213583
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TRIMEGESTONE
ChEMBL ID: CHEMBL2104765
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NOMEGESTROL
ChEMBL ID: CHEMBL2105722
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: NOMEGESTROL ACETATE
ChEMBL ID: CHEMBL1476022
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL1842):

Molecule: GEMTUZUMAB OZOGAMICIN
ChEMBL ID: CHEMBL1201506
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2000

Molecule: LINTUZUMAB
ChEMBL ID: CHEMBL2109150
Mechanism of Action: OTHER
Max Phase: 3.0
Molecule Type: Antibody

Molecule: M195
ChEMBL ID: CHEMBL2109267
Mechanism of Action: OTHER
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ONCOLYSIN M
ChEMBL ID: CHEMBL2109520
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: GEMTUZUMAB
ChEMBL ID: CHEMBL2108342
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody

Molecule: AVE-9633
ChEMBL ID: CHEMBL2109266
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody drug conjugate
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL234):

Molecule: LEVODOPA
ChEMBL ID: CHEMBL1009
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1970

Molecule: CHLORPROTHIXENE
ChEMBL ID: CHEMBL908
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: CARIPRAZINE HYDROCHLORIDE
ChEMBL ID: CHEMBL2024517
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015

Molecule: ETILEVODOPA
ChEMBL ID: CHEMBL1823681
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SARIZOTAN HYDROCHLORIDE
ChEMBL ID: CHEMBL2146110
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ADOPRAZINE
ChEMBL ID: CHEMBL221692
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BLONANSERIN
ChEMBL ID: CHEMBL178803
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: ABT-925
ChEMBL ID: CHEMBL439338
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TIAPRIDE
ChEMBL ID: CHEMBL84158
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MESDOPETAM
ChEMBL ID: CHEMBL4594447
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TRAZPIROBEN
ChEMBL ID: CHEMBL4650340
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2014):

Molecule: LY2940094
ChEMBL ID: CHEMBL3545406
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CEBRANOPADOL
ChEMBL ID: CHEMBL2364605
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: LY-2940094
ChEMBL ID: CHEMBL3304244
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SCH-486757
ChEMBL ID: CHEMBL4297427
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL1899):

Molecule: DOLASETRON MESYLATE
ChEMBL ID: CHEMBL2368924
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: ONDANSETRON
ChEMBL ID: CHEMBL46
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: GRANISETRON HYDROCHLORIDE
ChEMBL ID: CHEMBL1237080
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1993

Molecule: GRANISETRON
ChEMBL ID: CHEMBL289469
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1993

Molecule: PALONOSETRON HYDROCHLORIDE
ChEMBL ID: CHEMBL1720
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: ONDANSETRON HYDROCHLORIDE
ChEMBL ID: CHEMBL3186492
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: ALOSETRON HYDROCHLORIDE
ChEMBL ID: CHEMBL1200885
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: METOCLOPRAMIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200940
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: VORTIOXETINE HYDROBROMIDE
ChEMBL ID: CHEMBL2107387
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL1777):

Molecule: ATOVAQUONE
ChEMBL ID: CHEMBL1450
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4116):

Molecule: CAVOSONSTAT
ChEMBL ID: CHEMBL3989910
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: N6022
ChEMBL ID: CHEMBL1738699
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2888):

Molecule: LY404039
ChEMBL ID: CHEMBL375611
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LY2969822
ChEMBL ID: CHEMBL3545270
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: DECOGLURANT
ChEMBL ID: CHEMBL3301593
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: POMAGLUMETAD METHIONIL ANHYDROUS
ChEMBL ID: CHEMBL2110730
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL262):

Molecule: LY-2090314
ChEMBL ID: CHEMBL362558
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TIDEGLUSIB
ChEMBL ID: CHEMBL3545157
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ELRAGLUSIB
ChEMBL ID: CHEMBL483465
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2107):

Molecule: PLERIXAFOR
ChEMBL ID: CHEMBL18442
Mechanism of Action: PARTIAL AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: MSX-122
ChEMBL ID: CHEMBL3545330
Mechanism of Action: ANTAGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: BURIXAFOR
ChEMBL ID: CHEMBL3545224
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MOTIXAFORTIDE
ChEMBL ID: CHEMBL5095030
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: BALIXAFORTIDE
ChEMBL ID: CHEMBL4802129
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: CTCE-9908
ChEMBL ID: CHEMBL3544949
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Protein

Molecule: ULOCUPLUMAB
ChEMBL ID: CHEMBL3039543
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MAVORIXAFOR
ChEMBL ID: CHEMBL518924
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2534):

Molecule: AR-12
ChEMBL ID: CHEMBL1650595
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: UCN-01
ChEMBL ID: CHEMBL574737
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2148):

Molecule: CERDULATINIB
ChEMBL ID: CHEMBL4116008
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: R-348
ChEMBL ID: CHEMBL5314384
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TRICETAMIDE
ChEMBL ID: CHEMBL2106468
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: WHI-P131
ChEMBL ID: CHEMBL405130
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AT-9283
ChEMBL ID: CHEMBL495727
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: R-333
ChEMBL ID: CHEMBL3545159
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DECERNOTINIB
ChEMBL ID: CHEMBL3039513
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RITLECITINIB
ChEMBL ID: CHEMBL4085457
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: RITLECITINIB TOSYLATE
ChEMBL ID: CHEMBL5314649
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: FILGOTINIB
ChEMBL ID: CHEMBL3301607
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: FILGOTINIB MALEATE
ChEMBL ID: CHEMBL4298167
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: UPADACITINIB HEMIHYDRATE
ChEMBL ID: CHEMBL5315119
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2850):

Molecule: LY-2090314
ChEMBL ID: CHEMBL362558
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL3130):

Molecule: IDELALISIB
ChEMBL ID: CHEMBL2216870
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2014

Molecule: AMG-319
ChEMBL ID: CHEMBL4303596
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AZD-8186
ChEMBL ID: CHEMBL3408248
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CAL-263
ChEMBL ID: CHEMBL3545247
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: FIMEPINOSTAT
ChEMBL ID: CHEMBL3622533
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RP-6530
ChEMBL ID: CHEMBL3545141
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: UMBRALISIB TOSYLATE
ChEMBL ID: CHEMBL3989869
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021

Molecule: ZANDELISIB
ChEMBL ID: CHEMBL4650214
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ACALISIB
ChEMBL ID: CHEMBL4303323
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DUVELISIB
ChEMBL ID: CHEMBL3039502
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: TG100-115
ChEMBL ID: CHEMBL230011
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GSK-2269557
ChEMBL ID: CHEMBL5314409
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: INCB-40093
ChEMBL ID: CHEMBL3545054
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: COPANLISIB HYDROCHLORIDE
ChEMBL ID: CHEMBL3545068
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: COPANLISIB
ChEMBL ID: CHEMBL3218576
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: TENALISIB
ChEMBL ID: CHEMBL4297584
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LENIOLISIB
ChEMBL ID: CHEMBL3643413
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: PARSACLISIB
ChEMBL ID: CHEMBL4297615
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NEMIRALISIB
ChEMBL ID: CHEMBL2216859
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SELETALISIB
ChEMBL ID: CHEMBL4297648
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LENIOLISIB PHOSPHATE
ChEMBL ID: CHEMBL3989909
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: DUVELISIB MONOHYDRATE
ChEMBL ID: CHEMBL5315125
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4245):

Molecule: AFIMOXIFENE
ChEMBL ID: CHEMBL489
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL4005):

Molecule: BAY-1082439
ChEMBL ID: CHEMBL3644672
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: FIMEPINOSTAT
ChEMBL ID: CHEMBL3622533
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SERABELISIB
ChEMBL ID: CHEMBL3935857
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PKI-179
ChEMBL ID: CHEMBL1258517
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PWT-33579
ChEMBL ID: CHEMBL3545323
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ALPELISIB
ChEMBL ID: CHEMBL2396661
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: COPANLISIB HYDROCHLORIDE
ChEMBL ID: CHEMBL3545068
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: COPANLISIB
ChEMBL ID: CHEMBL3218576
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: INAVOLISIB
ChEMBL ID: CHEMBL4650215
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL3385):

Molecule: RAVOXERTINIB
ChEMBL ID: CHEMBL3544964
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MK-8353
ChEMBL ID: CHEMBL4213970
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ULIXERTINIB
ChEMBL ID: CHEMBL3590106
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL1955):

Molecule: JNJ-26483327
ChEMBL ID: CHEMBL3109738
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CATEQUENTINIB
ChEMBL ID: CHEMBL4303201
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TELATINIB
ChEMBL ID: CHEMBL2079588
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FAMITINIB
ChEMBL ID: CHEMBL1278146
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: IMC-3C5
ChEMBL ID: CHEMBL2109602
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: SUNITINIB
ChEMBL ID: CHEMBL535
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2708):

Molecule: CEP-1347
ChEMBL ID: CHEMBL290352
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL1847):

Molecule: ETAZOLATE
ChEMBL ID: CHEMBL356388
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for gpam_glycerol-3-phosphate_acyltransferase,_mitochondrial (ChEMBL ID: CHEMBL2742):

Molecule: PAZOPANIB HYDROCHLORIDE
ChEMBL ID: CHEMBL1201733
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: ENMD-2076
ChEMBL ID: CHEMBL482968
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MASITINIB
ChEMBL ID: CHEMBL1908391
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: DOVITINIB
ChEMBL ID: CHEMBL522892
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: RG-7444
ChEMBL ID: CHEMBL2109411
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: PEMIGATINIB
ChEMBL ID: CHEMBL4297522
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: E-7090
ChEMBL ID: CHEMBL3686884
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FGFR INHIBITOR DEBIO 1347
ChEMBL ID: CHEMBL3907479
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: HMPL-453
ChEMBL ID: CHEMBL4650297
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown
